Prof. Dr. İbrahim Başarıcı, MD
Timeline
Career milestones.
Scientific work
Selected peer-reviewed publications.
-
2025International Journal of Rheumatic Diseases«Case Report: A New TNFRSF1A Gene Mutation in a Turkish Family With TNF Receptor-Associated Periodic Syndrome (TRAPS)»· co-author
-
2025Medicina (Lithuania)«Comorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome»· co-author
-
2024Lab Medicine«Can lipid mediators and free fatty acids guide acute coronary syndrome diagnosis and treatment?»· co-author
-
2024Frontiers in Cardiovascular Medicine«Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study»· co-author
-
2023Anatolian Journal of Cardiology«The Definition of Sarcomeric and Non-Sarcomeric Gene Mutations in Hypertrophic Cardiomyopathy Patients»· co-author
-
2019Anatolian Journal of Cardiology«Risk assessment and survival of patients with pulmonary hypertension: Multicenter experience in Turkey»· first author
Where they practise
Direct contract with BergemHealth at every listed clinic.
Tell me about your case — I’ll read it personally.
Fill in the short form on the consultation page — diagnosis, preferred timing, attached records. We assemble a tumour board for your case and reply within 4 hours.
Open the consultation form- Reply within 4 hours during business hours
- Confidentiality guaranteed
- Coordinator-translator inside the doctor’s office
- Tumour board of 2–3 professors within 72 hours
Similar BergemHealth professors
Adjacent specialties and second opinions. Direct contracts, verified cases.